prijava
SARAJEVO, October 7 (FENA) – The Agency for Medicinal Products and Medical Devices of Bosnia and Herzegovina (ALMBIH) said on Wednesday that the quality of BCG vaccines imported into Bosnia and Herzegovina in 2026 was satisfactory and that no adverse reactions had been reported in the country. It also recommended that parents and pediatricians take no special measures in the case of children who have no symptoms.
Sadržaj dostupan isključivo pretplatnicima FENA servisa. Za više informacija o načinu i
uslovima korištenja servisa kontaktirajte marketing@fena.ba.
(FENA) A. B.
